第 1 頁 共 6 頁 v 1.3.0 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2025年10月23日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | ...

Core Viewpoint - On October 22, 35 Hong Kong-listed companies conducted share buybacks, totaling 10.4965 million shares and an amount of 52.7745 million HKD [1][2]. Group 1: Buyback Details - The company with the highest buyback amount on October 22 was AAC Technologies, with a buyback amount of 11.9098 million HKD for 300,000 shares [1][2]. - Linklogis Technology-W followed with a buyback of 2.430 million shares, amounting to 7.4708 million HKD [1][2]. - Mengniu Dairy repurchased 500,000 shares for 7.1714 million HKD [1][2]. Group 2: Year-to-Date Buyback Totals - AAC Technologies has conducted multiple buybacks this year, with a cumulative buyback amount of 858.628 million HKD [2]. - Linklogis Technology-W's total buyback amount for the year reached 225.0668 million HKD [2]. - Mengniu Dairy's year-to-date buyback amount stands at 45.832 million HKD [2]. Group 3: Buyback Volume Rankings - The highest number of shares repurchased on October 22 was by Linklogis Technology-W, with 2.43 million shares [1][2]. - Other notable buybacks in terms of volume included MorningX Technology with 1.064 million shares and China Hengyou Group with 1 million shares [1][2].

Summary of Key Points Core Viewpoint - A total of 30 companies, including major players like 瑞声科技 (AAC Technologies) and 蒙牛乳业 (Mengniu Dairy), conducted share buybacks on October 22, 2025, indicating a trend of companies returning capital to shareholders amidst market conditions. Group 1: Buyback Details - 瑞声科技 (AAC Technologies) had the largest buyback amount, repurchasing 300,000 shares for a total of 11.90 million yuan [1] - 联易融科技-W (Lianyi Technology) repurchased 2.43 million shares, totaling 7.47 million yuan, representing 3.288% of its total share capital [2] - 蒙牛乳业 (Mengniu Dairy) bought back 500,000 shares for 7.17 million yuan, which is 0.517% of its total share capital [2] Group 2: Other Notable Buybacks - 康臣药业 (Kangchen Pharmaceutical) repurchased 283,000 shares for 4.33 million yuan, accounting for 7.969% of its total share capital [2] - 连连数字 (Lianlian Digital) bought back 440,000 shares for 3.54 million yuan, which is 0.138% of its total share capital [2] - 固生堂 (Gushengtang) repurchased 91,300 shares for 2.75 million yuan, representing 2.076% of its total share capital [2] Group 3: Additional Companies Involved - 绿城服务 (Greentown Service) repurchased 216,000 shares for 989,300 yuan, which is 0.007% of its total share capital [2] - 歌礼制药-B (Galactico Pharmaceutical) bought back 100,000 shares for 926,500 yuan, accounting for 0.068% of its total share capital [2] - 医渡科技 (Yidu Technology) repurchased 17,700 shares for 99,800 yuan, representing 0.330% of its total share capital [2]

Core Viewpoint - 医渡科技 is actively repurchasing its shares, indicating confidence in its market position and future growth potential [1] Group 1: Share Buyback Activity - On October 22, 医渡科技 repurchased 17,700 shares for a total of 100,000 HKD [1] - Since September 26, the company has completed 8 share buybacks, with a total expenditure exceeding 20.4 million HKD [1] Group 2: Southbound Capital Inflows - On October 17, southbound funds net purchased 4.035 million shares of 医渡科技, accounting for 28.56% of the day's trading volume [1] - The net purchase amount by southbound funds on that day was approximately 22.88 million HKD, marking six consecutive days of net buying, with a cumulative total of 100 million HKD [1] Group 3: Product Development and Implementation - 医渡科技 recently launched "Doctor Clinical Copilot," which has developed 25 intelligent scenarios, enabling a comprehensive process from intelligent medical record generation to patient education and smart nursing [1] - The self-developed "医渡大模型" and intelligent solutions have been implemented in over 110 hospitals nationwide [1]

Core Viewpoint - 医渡科技 (02158) announced a share buyback plan, intending to repurchase 17,700 shares at a cost of HKD 99.8 million [1] Group 1 - The company will execute the buyback on October 22, 2025 [1] - The total expenditure for the buyback is approximately HKD 99.8 million [1] - The number of shares to be repurchased is 17,700 [1]

智通财经APP讯，医渡科技(02158)发布公告，于2025年10月22日斥资9.98万港元回购1.77万股。 ...

格隆汇10月22日丨医渡科技(02158.HK)公告，10月22日耗资10万港元回购1.8万股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 醫渡科技有限公司 呈交日期： 2025年10月22日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02158 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 | ...

Group 1 - Multiple companies conducted share buybacks on October 21, 2025, with a total of 30 companies listed [1] - The largest buyback was by Cloud Factory (N23027), repurchasing 2.1 million shares for a total of 8.22 million yuan [1][2] - Other notable buybacks include Linklogis Technology (W09959) with 2.38 million shares for 7.45 million yuan and Mengniu Dairy (02319) with 500,000 shares for 7.26 million yuan [2] Group 2 - Cumulative buyback amounts for the year show Cloud Factory (N23027) has repurchased a total of 26.62 million shares, representing 5.786% of its total share capital [2] - Linklogis Technology (W09959) has repurchased 67.82 million shares, accounting for 3.174% of its total share capital [2] - Other companies with significant cumulative buybacks include Stone Four Pharmaceutical (02005) with 39.20 million shares (1.328%) and Kangchen Pharmaceutical (01681) with 6.50 million shares (7.637%) [2][3]

Core Viewpoint - The company, Yidu Tech, has been actively repurchasing its shares, indicating confidence in its market position and future growth potential [1] Group 1: Share Buyback Activity - On October 21, Yidu Tech repurchased nearly 60,000 shares at a cost of 340,000 Hong Kong dollars [1] - From September 26 to the present, the company has completed seven share buybacks, with a total expenditure exceeding 20.3 million Hong Kong dollars [1] Group 2: Product Development - Yidu Tech recently launched the "Doctor Clinical Copilot," which has undergone extensive refinement across 25 intelligent scenarios [1] - The product enables a comprehensive process from intelligent medical record generation, AI pre-consultation, evidence-based decision support, to patient education and smart nursing [1] - It allows doctors to customize personalized assistants, achieving an "All in One" smart support solution [1]